跳至主要内容
临床试验/EUCTR2007-005274-31-IT
EUCTR2007-005274-31-IT进行中(未招募)不适用

Efficacy assessment of tetracycline in patients with progressive external ophthalmoplegia. - TETRA-PEO

AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2008年10月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. PEO or PEO plus, confirmed by histopathologic reports (presence of ragged red fibres in muscular biopsy), biochemical reports (compromising of mitochondrial respiration) and molecular reports (deletions or mutations of mtDNA); b. Age from 18 years to 68 years; c. Negative pregnancy test in fertile women.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • a. Poor compliance with previous treatments; b. Patients that partecipate in other clinical trial; c. Patients with serious organ's diseases (cardiologic, neurologic, neoplastic, pneumologic and endocrinologic disease); d. Patients with history of sensitivity or intolerance of tetracycline and patients with concomitant diseases that contraindicate tetracycline administration (myasthenia gravis, systemic erythematus lupus, renal or hepatic diseases).

研究者

发起方
AZIENDA OSPEDALIERA PISANA

相似试验